Sector Update: Health Care Stocks Advance Pre-Bell Thursday

MT Newswires Live11-14

Health care stocks were advancing pre-bell Thursday as the iShares Biotechnology ETF (IBB) was marginally higher and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently.

ClearPoint Neuro (CLPT) shares were up nearly 10% after the company said the US Food and Drug Administration has granted De Novo marketing authorization for its SmartFlow Neuro Cannula for the delivery of PTC Therapeutics' Kebilidi gene therapy to targeted regions within the brain.

PTC Therapeutics (PTCT) shares were over 2% higher after the company said the US Food and Drug Administration has accelerated approval of Kebilidi, the company's gene therapy for aromatic L-amino acid decarboxylase deficiency.

BeiGene (BGNE) shares were 0.8% higher after the company said it plans to change its name to BeOne Medicines, subject to shareholder approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment